Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in ...

Levothyroxine, commercially known as Synthroid among other names, is commonly used to treat an underactive thyroid.

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

Levothyroxine is a medication commonly used to treat hypothyroidism, yet a new study has found a link leading to a heightened ...

Fact checked by Nick BlackmerLevothyroxine, a common medication for hypothyroidism sold as Synthroid, is linked to bone loss ...

Women with osteoporosis will have to break a bone to qualify for drug treatment under proposed Health Service rules. Even then, some fracture victims may be refused. Millions of women would lose ...

Thousands of Brits who take drugs for a common hormone condition could be at risk of bone loss, concerning research suggested today. Roughly one in five Britons are affected by an underactive ...

In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

The global blood and bone marrow cancer drug market size was US$ 39.1 billion in 2021. The global blood and bone marrow cancer drug market is forecast to grow to US$ 79.8 billion by 2030 by ...

ONE of the most commonly prescribed drugs in the UK, used to treat a hormone condition, may be linked to a bone snapping disease, a study has found. An underactive thyroid or hypothyroidism is ...

Tiny implantable sensors are helping University of Oregon researchers optimize the process of recovery from severe bone injuries.